• Exchange: Stockholm
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

ORX:SS

113.7500 SEK 0.5000 0.44%

As of 11:02:17 ET on 04/17/2014.

Snapshot for Orexo AB (ORX)

Open: 114.5000 Day's Range: 113.2500 - 114.5000 Volume: 20,461
Previous Close: 114.2500 52wk Range: 48.5000 - 183.5000 1-Yr Rtn: +133.09%

Stock Chart for ORX

No chart data available.
  • ORX:SS 113.7500
  • 1D
  • 1M
  • 1Y
114.2500
Interactive ORX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ORX

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) 47.6340
Relative P/E vs. OMX -
Earnings Per Share (SEK) (ttm) -5.1760
Est. EPS (SEK) (12/2014) 2.3880
Est. PEG Ratio -
Market Cap (M SEK) 3,746.78
Shares Outstanding (M) 32.94
30 Day Average Volume 184,600
Price/Book (mrq) 22.3913
Price/Sale (ttm) 7.9712
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 04/25/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ORX

  • Revenue
  • Net Income (M/SEK)
  • Profit Margin (%)

Company Profile & Key Executives for ORX

Orexo AB is a product oriented drug delivery company that develops new pharmaceuticals by further develop existing products. The Company specializes in drugs in tablet form especially sublingual pills and often works together with scientists and other corporations. Orexo sells internationally.

Martin NicklassonChairmanNikolaj SorensenChief Executive Officer
Henrik JuuelExec VP/CFO
More Company Profile & Key Executives for ORX

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil